GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xspray Pharma publ XSPRAY.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

11.70

+8.33%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−SEK 171.4m

FY2016FY2025

Free cash flow

−SEK 222.3m

FY2016FY2025

Shareholders' equity

SEK 604.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue———————SEK 277,000SEK 331,546SEK 792,000
Research and developmentSEK 8.6mSEK 82.0mSEK 33.6mSEK 22.2mSEK 38.6mSEK 6.5mSEK 3.4mSEK 5.5mSEK 3.4m—
Operating income−SEK 156.9m−SEK 283.2m−SEK 181.7m−SEK 133.1m−SEK 98.0m−SEK 53.5m−SEK 45.7m−SEK 23.2m−SEK 13.3m−SEK 4.1m
Net income−SEK 171.4m−SEK 285.5m−SEK 179.7m−SEK 130.3m−SEK 96.7m−SEK 52.3m−SEK 45.8m−SEK 23.1m−SEK 13.2m−SEK 4.1m
Diluted earnings per share-4.11-8.21-6.09-5.81-5.03-3.10-3.04-1.68-1.07-1.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 769.3mSEK 796.3mSEK 765.3mSEK 585.4mSEK 622.9mSEK 605.3mSEK 400.7mSEK 312.5mSEK 161.4mSEK 51.9m
Cash and short-term investmentsSEK 153.7mSEK 208.2mSEK 166.3mSEK 120.2mSEK 271.9mSEK 325.6mSEK 209.9mSEK 221.3mSEK 115.5mSEK 28.8m
Total liabilitiesSEK 164.7mSEK 173.2mSEK 71.8mSEK 29.4mSEK 31.2mSEK 22.7mSEK 27.0mSEK 10.8mSEK 5.8mSEK 5.4m
DebtSEK 170.1mSEK 128.2mSEK 36.8mSEK 2.1mSEK 3.2mSEK 4.9mSEK 5.3m———
Shareholders' equitySEK 604.6mSEK 623.1mSEK 693.4mSEK 556.0mSEK 591.8mSEK 582.6mSEK 373.7mSEK 301.7mSEK 155.7mSEK 46.5m
Shares outstanding42m35m30m22m19m17m15m14m12m4m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 193.2m−SEK 222.4m−SEK 203.3m−SEK 110.2m−SEK 51.6m−SEK 47.8m−SEK 34.2m−SEK 17.7m−SEK 11.0m−SEK 1.7m
Capital spending−SEK 29.2m−SEK 42.1m−SEK 54.1m−SEK 128.3m−SEK 96.0m−SEK 97.2m−SEK 92.0m−SEK 47.0m−SEK 24.6m−SEK 19.6m
Free cash flow−SEK 222.3m−SEK 264.5m−SEK 257.4m−SEK 238.5m−SEK 147.6m−SEK 145.0m−SEK 126.2m−SEK 64.7m−SEK 35.7m−SEK 21.4m
Dividends paid———−SEK 2.2m−SEK 2.2m−SEK 1.0m————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 31.0m−SEK 31.7m−SEK 33.4m−SEK 44.7m−SEK 41.1m−SEK 39.5m−SEK 80.1m−SEK 82.7m
Net income−SEK 39.8m−SEK 35.4m−SEK 37.0m−SEK 47.3m−SEK 44.9m−SEK 42.3m−SEK 82.0m−SEK 82.2m
Diluted earnings per share-0.87-0.77-0.89-1.13-1.07-1.01-2.36-2.37
Cash from operations−SEK 36.0m−SEK 30.0m−SEK 41.0m−SEK 41.0m−SEK 44.0m−SEK 66.0m−SEK 61.0m−SEK 41.0m
Capital spending−SEK 10.0m−SEK 1.0m−SEK 1.0m−SEK 27.0m−SEK 6.0m−SEK 14.0m−SEK 19.0m−SEK 9.0m
Free cash flow−SEK 46.0m−SEK 31.0m−SEK 42.0m−SEK 68.0m−SEK 50.0m−SEK 80.0m−SEK 80.0m−SEK 50.0m
Total assetsSEK 811.2mSEK 736.4mSEK 769.3mSEK 820.2mSEK 697.0mSEK 737.7mSEK 796.3mSEK 667.7m
Cash and short-term investmentsSEK 179.9mSEK 120.7mSEK 153.7mSEK 198.0mSEK 73.8mSEK 125.7mSEK 208.2mSEK 74.8m
DebtSEK 128.2mSEK 127.5mSEK 148.4mSEK 148.9mSEK 125.7mSEK 127.0mSEK 128.2mSEK 33.6m
Shareholders' equitySEK 637.5mSEK 569.4mSEK 604.6mSEK 641.7mSEK 535.5mSEK 580.5mSEK 623.1mSEK 585.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income5.6%24.0%29.2%
Net income9.6%26.8%30.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-7.7-2.1-2.8-4.2-5.4-13.6-3.5-5.4-7.5
Price to sales———————448.5297.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.